Research Study

Perioperative Anticoagulant Use (Dabigatran, Rivaroxaban, or Apixaban) for Elective Surgery/Procedure Evaluation in Patients With Atrial Fibrillation (AF)
Principal Investigator 
Agnes Lee

Overview

Body Locations and Systems 
Atrial Fibrillation
ClinicalTrials.gov# 
NCT02228798
Status 
Recruiting
Study Start/End 
Nov 1, 2014 to Nov 1, 2017
Locations 
Vancouver General Hospital
Name/Title 
Myra San Antonio, Research Coordinator
Phone 
604-875-4111 ext.69277
Purpose of Study 

The aim of the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study, is to establish a safe, standardized protocol for the perioperative management of patients with atrial fibrillation (AF) who are receiving a novel oral anticoagulant (NOAC) drug, either dabigatran, rivaroxaban or apixaban, and require an elective surgery/procedure.


 

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.